9939.HK

Kintor Pharmaceutical Limited [9939.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

9939.HK Stock Summary

Top 10 Correlated ETFs

9939.HK


Top 10 Correlated Stocks

9939.HK


In the News

9939.HK Financial details

Company Rating
Buy
Market Cap
718.23M
Income
-203.88M
Revenue
174.5K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
290
Optionable
No
Shortable
Yes
Earnings
28 Aug 2023
P/E
-0.55
Forward P/E
-1.1
PEG
0.07
P/S
-
P/B
0.35
P/C
-
P/FCF
-0.65
Quick Ratio
2.75
Current Ratio
4.74
Debt / Equity
0.24
LT Debt / Equity
0.16
-
-
EPS (TTM)
-0.56
EPS next Y
-1.34
EPS next Q
-
EPS this Y
6.75%
EPS next Y
141.6%
EPS next 5Y
141.6%
EPS last 5Y
54.22%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
100%
SMA50
-
SMA100
-33.33%
Inst Own
-
Inst Trans
-
ROA
-46%
ROE
-61%
ROC
-0.54%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
435.29M
Shs Float
310.42M
-
-
-
-
Target Price
-
52W Range
1.18-10.94
52W High
-85.2%
52W Low
+48%
RSI
50
Rel Volume
0.71
Avg Volume
16.46M
Volume
11.67M
Perf Week
-10.84%
Perf Month
-3.9%
Perf Quarter
-58.54%
Perf Half Y
-59.45%
-
-
-
-
Beta
-0.134
-
-
Volatility
0.06%, 0.16%
Prev Close
-1.33%
Price
1.48
Change
0.68%

9939.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0000.10
Net income per share
-0.29-0.63-1.64-2.37-2.53
Operating cash flow per share
-0.31-0.62-1.23-2.95-2.55
Free cash flow per share
-0.36-0.82-1.54-3.25-2.63
Cash per share
0.370.534.492.962.32
Book value per share
0.6814.874.643.97
Tangible book value per share
0.190.494.173.893.26
Share holders equity per share
0.6814.874.643.97
Interest debt per share
0.20.180.730.460.78
Market cap
6.92B7.08B2.72B3.58B3.27B
Enterprise value
6.85B6.95B1.88B2.81B2.69B
P/E ratio
-63.75-30.22-5.35-4.24-3.43
Price to sales ratio
9.91K00104.520
POCF ratio
-60.2-31.06-7.14-3.4-3.41
PFCF ratio
-51.5-23.44-5.7-3.09-3.31
P/B Ratio
27.4819.161.82.162.19
PTB ratio
27.4819.161.82.162.19
EV to sales
9.81K0082.010
Enterprise value over EBITDA
-66.41-30.75-3.74-3.38-2.9
EV to operating cash flow
-59.61-30.49-4.92-2.67-2.8
EV to free cash flow
-50.99-23.01-3.93-2.43-2.72
Earnings yield
-0.02-0.03-0.19-0.24-0.29
Free cash flow yield
-0.02-0.04-0.18-0.32-0.3
Debt to equity
0.280.170.150.10.19
Debt to assets
0.160.120.120.080.14
Net debt to EBITDA
0.660.581.680.930.62
Current ratio
2.011.558.396.944.74
Interest coverage
-27.03-126.14-149.5-334.85-115.37
Income quality
1.060.980.751.251.01
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
26.53001.310
Research and developement to revenue
133.520022.430
Intangibles to total assets
0.430.340.120.130.13
Capex to operating cash flow
0.170.330.250.10.03
Capex to revenue
-27.8200-3.090
Capex to depreciation
-7.95-15.88-14.79-10.06-1.5
Stock based compensation to revenue
0001.090
Graham number
2.123.7813.4215.7315.05
ROIC
-0.32-0.52-0.29-0.46-0.53
Return on tangible assets
-0.45-0.64-0.31-0.47-0.53
Graham Net
-0.090.033.382.31.64
Working capital
109.96M78.03M1.25B1.31B1.19B
Tangible asset value
69.58M180.95M1.29B1.39B1.23B
Net current asset value
46.42M36.9M1.08B1.11B947.92M
Invested capital
0.280.170.150.10.19
Average receivables
00000
Average payables
049.14M54.34M36.69M61.58M
Average inventory
000175.68M477.43M
Days sales outstanding
00000
Days payables outstanding
9.69K0000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
0.040000
Inventory turnover
00000
ROE
-0.43-0.63-0.34-0.51-0.64
Capex per share
-0.05-0.2-0.31-0.3-0.07

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2021-06-302021-12-312022-06-302022-12-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
00000
Enterprise value
-1.09B-770.42M-102.73M-578.7M-368.75M
P/E ratio
00000
Price to sales ratio
00000
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
00000
PTB ratio
00000
EV to sales
00000
Enterprise value over EBITDA
00000
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
0.060.10.20.190.24
Debt to assets
0.060.080.130.140.17
Net debt to EBITDA
00000
Current ratio
27.496.943.444.744.89
Interest coverage
00000
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.090.130.130.130.13
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
00000
ROIC
00000
Return on tangible assets
00000
Graham Net
00000
Working capital
1.85B1.31B834.39M1.19B1.06B
Tangible asset value
1.95B1.39B951.86M1.23B1.09B
Net current asset value
1.68B1.11B614.01M947.92M790.11M
Invested capital
0.060.10.20.190.24
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
00000
Capex per share
00000

9939.HK Frequently Asked Questions

What is Kintor Pharmaceutical Limited stock symbol ?

Kintor Pharmaceutical Limited is a CN stock and trading under the symbol 9939.HK

What is Kintor Pharmaceutical Limited stock quote today ?

Kintor Pharmaceutical Limited stock price is $1.48 today.

Is Kintor Pharmaceutical Limited stock public?

Yes, Kintor Pharmaceutical Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap